ctrl K

Watchlist Price Alert

Ensysce Biosciences Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

2.26

0.04 (1.80%)

At close: Jun 27, 2025, 12:12 PM

Ensysce Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	5.21M	2.23M	2.52M	3.53M	3.93M	1.76M	n/a	n/a
Cost of Revenue	7.22M	7.59M	19.84M	151.00	201.00	3.33M	1.56M	n/a
Gross Profit	5.21M	-5.36M	-17.31M	3.53M	2.56M	-1.64M	-1.56M	n/a
Operating Income	-6.73M	-10.72M	-24.22M	-19.87M	-1.61M	-3.33M	-959K	-147K
Interest Income	n/a	n/a	1.25M	3.21M	719.65K	4.25M	3.63M	n/a
Pretax Income	-7.99M	-10.63M	-24.21M	-29.15M	-161K	921.15K	2.68M	-27.56K
Net Income	-7.99M	-10.61M	-24.17M	-29.08M	56.77K	365.95K	-1.34M	-31.19K
Selling & General & Admin	4.72M	5.36M	6.91M	18.71M	1.16M	3.33M	n/a	146.69K
Research & Development	7.22M	7.59M	19.84M	4.69M	4.39M	n/a	n/a	n/a
Other Expenses	-7.22M	-7.59M	-2.52M	-3.53M	-3.93M	-3.4M	n/a	n/a
Operating Expenses	4.72M	5.36M	6.91M	18.71M	1.61M	3.33M	-600K	146.69K
Interest Expense	1.29M	353.94K	1.25M	1.29M	995.5K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	11.94M	12.95M	26.75M	23.4M	5.54M	10.33M	959.24K	146.69K
Income Tax Expense	n/a	n/a	753.88K	-151	777.85K	-555K	553.92K	3.63K
Shares Outstanding (Basic)	1.75M	2.26M	179.93K	84.02K	4.46M	6.09M	6.01M	5.98M
Shares Outstanding (Diluted)	1.75M	2.26M	179.93K	84.02K	6.37M	6.09M	6.01M	5.98M
EPS (Basic)	-4.57	-4.69	-139.44	-355.68	0.56	0.24	-0.22	-0.01
EPS (Diluted)	-4.57	-4.69	-139.44	-346.9	0.56	0.24	-0.22	-0.01
EBITDA	-6.73M	-10.72M	-24.22M	-19.87M	-1.61M	921.15K	2.68M	-27.55K
EBIT	-6.73M	-10.72M	-24.22M	-19.87M	-1.61M	921.15K	2.68M	-27.55K
Depreciation & Amortization	4.00	-3	151.00	151.00	201.00	201.00	n/a	n/a